IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF

IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF

The invention describes an efficient platform for antibody manufacturing and formulation that provides i) cell culture process with improved feeding strategy resulting in high antibody titer between 2 gm/L to 5 gm/L; ii) improved purification process showing optimal percentage recovery, high purity...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: REDDY, Peddi Reddy Srinivas, RAVINDRA, Yeolekar Leena, CHAHAR, Singh Digamber, SINGH, Chouhan Pankaj, MHALASAKANT, Dhere Rajeev, SHANKAR, Pisal Sambhaji, DATTATRAY, Avalaskar Nikhil
Format: Patent
Sprache:eng
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator REDDY, Peddi Reddy Srinivas
RAVINDRA, Yeolekar Leena
CHAHAR, Singh Digamber
SINGH, Chouhan Pankaj
MHALASAKANT, Dhere Rajeev
SHANKAR, Pisal Sambhaji
DATTATRAY, Avalaskar Nikhil
description The invention describes an efficient platform for antibody manufacturing and formulation that provides i) cell culture process with improved feeding strategy resulting in high antibody titer between 2 gm/L to 5 gm/L; ii) improved purification process showing optimal percentage recovery, high purity monomer content, minimum aggregation/particulate formation, minimum impurity levels; and iii) high concentration stable liquid formulation with optimal osmolality and low viscosity across different temperature excursions and devoid of aggregation. The preferred antibodies include IgG1 monoclonal antibody specific to the Dengue virus epitope in domain III of the E protein and IgG1 monoclonal antibody specific to the rabies virus surface G glycoprotein.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ZA201904046B</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ZA201904046B</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ZA201904046B3</originalsourceid><addsrcrecordid>eNqNjsFKA0EMhvfioWjfId4V1rYIHrMz2d3ATKbMZCrtpRQZT6KF9hH7YE6roMeeAsmX__snzYn9MoYVWfCkY7AJ-hCBZEQxLAOgKHfBrqFSNhvlFesaWMCj9-gYBQw5ByY7zZEqX5NY2PPm8j4MkQZUDgI2x_PKhldJGgn9w9nls_s5V4GhlChdMpJi5-hP_49MEDpFltpZR4oU-rvm5n33cSjT33nb3PekZnws-69tOex3b-WzHLcbnLVPL-2iXTx382uYb3ZRT60</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF</title><source>esp@cenet</source><creator>REDDY, Peddi Reddy Srinivas ; RAVINDRA, Yeolekar Leena ; CHAHAR, Singh Digamber ; SINGH, Chouhan Pankaj ; MHALASAKANT, Dhere Rajeev ; SHANKAR, Pisal Sambhaji ; DATTATRAY, Avalaskar Nikhil</creator><creatorcontrib>REDDY, Peddi Reddy Srinivas ; RAVINDRA, Yeolekar Leena ; CHAHAR, Singh Digamber ; SINGH, Chouhan Pankaj ; MHALASAKANT, Dhere Rajeev ; SHANKAR, Pisal Sambhaji ; DATTATRAY, Avalaskar Nikhil</creatorcontrib><description>The invention describes an efficient platform for antibody manufacturing and formulation that provides i) cell culture process with improved feeding strategy resulting in high antibody titer between 2 gm/L to 5 gm/L; ii) improved purification process showing optimal percentage recovery, high purity monomer content, minimum aggregation/particulate formation, minimum impurity levels; and iii) high concentration stable liquid formulation with optimal osmolality and low viscosity across different temperature excursions and devoid of aggregation. The preferred antibodies include IgG1 monoclonal antibody specific to the Dengue virus epitope in domain III of the E protein and IgG1 monoclonal antibody specific to the rabies virus surface G glycoprotein.</description><language>eng</language><creationdate>2022</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220223&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201904046B$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20220223&amp;DB=EPODOC&amp;CC=ZA&amp;NR=201904046B$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>REDDY, Peddi Reddy Srinivas</creatorcontrib><creatorcontrib>RAVINDRA, Yeolekar Leena</creatorcontrib><creatorcontrib>CHAHAR, Singh Digamber</creatorcontrib><creatorcontrib>SINGH, Chouhan Pankaj</creatorcontrib><creatorcontrib>MHALASAKANT, Dhere Rajeev</creatorcontrib><creatorcontrib>SHANKAR, Pisal Sambhaji</creatorcontrib><creatorcontrib>DATTATRAY, Avalaskar Nikhil</creatorcontrib><title>IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF</title><description>The invention describes an efficient platform for antibody manufacturing and formulation that provides i) cell culture process with improved feeding strategy resulting in high antibody titer between 2 gm/L to 5 gm/L; ii) improved purification process showing optimal percentage recovery, high purity monomer content, minimum aggregation/particulate formation, minimum impurity levels; and iii) high concentration stable liquid formulation with optimal osmolality and low viscosity across different temperature excursions and devoid of aggregation. The preferred antibodies include IgG1 monoclonal antibody specific to the Dengue virus epitope in domain III of the E protein and IgG1 monoclonal antibody specific to the rabies virus surface G glycoprotein.</description><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2022</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjsFKA0EMhvfioWjfId4V1rYIHrMz2d3ATKbMZCrtpRQZT6KF9hH7YE6roMeeAsmX__snzYn9MoYVWfCkY7AJ-hCBZEQxLAOgKHfBrqFSNhvlFesaWMCj9-gYBQw5ByY7zZEqX5NY2PPm8j4MkQZUDgI2x_PKhldJGgn9w9nls_s5V4GhlChdMpJi5-hP_49MEDpFltpZR4oU-rvm5n33cSjT33nb3PekZnws-69tOex3b-WzHLcbnLVPL-2iXTx382uYb3ZRT60</recordid><startdate>20220223</startdate><enddate>20220223</enddate><creator>REDDY, Peddi Reddy Srinivas</creator><creator>RAVINDRA, Yeolekar Leena</creator><creator>CHAHAR, Singh Digamber</creator><creator>SINGH, Chouhan Pankaj</creator><creator>MHALASAKANT, Dhere Rajeev</creator><creator>SHANKAR, Pisal Sambhaji</creator><creator>DATTATRAY, Avalaskar Nikhil</creator><scope>EVB</scope></search><sort><creationdate>20220223</creationdate><title>IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF</title><author>REDDY, Peddi Reddy Srinivas ; RAVINDRA, Yeolekar Leena ; CHAHAR, Singh Digamber ; SINGH, Chouhan Pankaj ; MHALASAKANT, Dhere Rajeev ; SHANKAR, Pisal Sambhaji ; DATTATRAY, Avalaskar Nikhil</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ZA201904046B3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2022</creationdate><toplevel>online_resources</toplevel><creatorcontrib>REDDY, Peddi Reddy Srinivas</creatorcontrib><creatorcontrib>RAVINDRA, Yeolekar Leena</creatorcontrib><creatorcontrib>CHAHAR, Singh Digamber</creatorcontrib><creatorcontrib>SINGH, Chouhan Pankaj</creatorcontrib><creatorcontrib>MHALASAKANT, Dhere Rajeev</creatorcontrib><creatorcontrib>SHANKAR, Pisal Sambhaji</creatorcontrib><creatorcontrib>DATTATRAY, Avalaskar Nikhil</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>REDDY, Peddi Reddy Srinivas</au><au>RAVINDRA, Yeolekar Leena</au><au>CHAHAR, Singh Digamber</au><au>SINGH, Chouhan Pankaj</au><au>MHALASAKANT, Dhere Rajeev</au><au>SHANKAR, Pisal Sambhaji</au><au>DATTATRAY, Avalaskar Nikhil</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF</title><date>2022-02-23</date><risdate>2022</risdate><abstract>The invention describes an efficient platform for antibody manufacturing and formulation that provides i) cell culture process with improved feeding strategy resulting in high antibody titer between 2 gm/L to 5 gm/L; ii) improved purification process showing optimal percentage recovery, high purity monomer content, minimum aggregation/particulate formation, minimum impurity levels; and iii) high concentration stable liquid formulation with optimal osmolality and low viscosity across different temperature excursions and devoid of aggregation. The preferred antibodies include IgG1 monoclonal antibody specific to the Dengue virus epitope in domain III of the E protein and IgG1 monoclonal antibody specific to the rabies virus surface G glycoprotein.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_ZA201904046B
source esp@cenet
title IMPROVED METHODS FOR ENHANCING ANTIBODY PRODUCTIVITY IN MAMMALIAN CELL CULTURE AND MINIMIZING AGGREGATION DURING DOWNSTREAM, FORMULATION PROCESSES AND STABLE ANTIBODY FORMULATIONS OBTAINED THEREOF
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-22T15%3A55%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=REDDY,%20Peddi%20Reddy%20Srinivas&rft.date=2022-02-23&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EZA201904046B%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true